UK stands by nasal flu vaccine for children as US doctors are told to stop using itBMJ 2016; 353 doi: http://dx.doi.org/10.1136/bmj.i3546 (Published 27 June 2016) Cite this as: BMJ 2016;353:i3546
- Nigel Hawkes
The £100m (€130m; $150m) a year childhood flu vaccination campaign in the United Kingdom will continue despite evidence from the United States that the inhaled vaccine is ineffective.
Public Health England (PHE) said that its data contradict those of the US Advisory Committee on Immunization Practices, which recently advised the Centers for Disease Control and Prevention (CDC) to stop vaccinating children because, for the past three flu seasons, the vaccine seemed to have little effect.
All children in the UK aged 2 have been offered vaccination against flu since September 2013, and the programme was extended last year to include infant school children.1 It is gradually being rolled out to include all children aged 2 to 17.
PHE published provisional figures for the UK that showed that the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial